Search research articles
Contact Us
Filters
Showing results (471-480 of 575) with videos related to
Page
of 58
Sort By:
The Journal of Rheumatology
|
January 15, 2023
Safety of Guselkumab With and Without Prior Tumor Necrosis Factor Inhibitor Treatment: Pooled Results Across 4 Studies in Patients With Psoriatic Arthritis
Proton Rahman, Wolf-Henning Boehncke, Philip J Mease, et al.
Rheumatology and Therapy
|
May 5, 2025
Correction: Safety and Efficacy of Bimekizumab in Patients with Psoriatic Arthritis: 2-Year Results from Two Phase 3 Studies
Philip J Mease, Joseph F Merola, Yoshiya Tanaka, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
March 28, 2026
Ixekizumab With Tirzepatide Achieved Greater Disease Control Than Ixekizumab Alone in Adults With Psoriatic Arthritis and Overweight or Obesity: Results From a Randomized Clinical Trial
Joseph F Merola, Philip Mease, Alan Kivitz, et al.
Nature Medicine
|
October 6, 2025
Sonelokimab, an IL-17A/IL-17F-inhibiting nanobody for active psoriatic arthritis: a randomized, placebo-controlled phase 2 trial
Iain B McInnes, Laura C Coates, Philip J Mease, et al.
Seminars in Arthritis and Rheumatism
|
August 16, 2021
OMERACT Filter 2.1 instrument selection for physical function domain in psoriatic arthritis: Provisional endorsement for HAQ-DI and SF-36 PF
Ying-Ying Leung, Ana-Maria Orbai, Pil Hojgaard, et al.
RMD Open
|
August 25, 2025
Efficacy of risankizumab across GRAPPA domains in psoriatic arthritis: a pooled analysis of patients from the phase 3 KEEPsAKE 1 and 2 studies
Laura C Coates, Ricardo Blanco, Frank Behrens, et al.
Rheumatology and Therapy
|
August 31, 2024
Safety and Efficacy of Bimekizumab in Patients with Psoriatic Arthritis: 2-Year Results from Two Phase 3 Studies
Philip J Mease, Joseph F Merola, Yoshiya Tanaka, et al.
Rheumatology and Therapy
|
May 10, 2025
Summary of Research: Safety and Efficacy of Bimekizumab in Patients with Psoriatic Arthritis: 2-Year Results from Two Phase 3 Studies
Philip J Mease, Joseph F Merola, Yoshiya Tanaka, et al.
Seminars in Arthritis and Rheumatism
|
September 14, 2020
Clinical trial discrimination of physical function instruments for psoriatic arthritis: A systematic review
Ying-Ying Leung, Richard Holland, Ashish J Mathew, et al.
JMIR Research Protocols
|
August 15, 2025
Effects of Acute Time-Restricted Eating on Inflammation in Individuals With Psoriasis: Protocol for a Case-Control, Prospective Study
Sinibaldo Romero Arocha, Kim Han, Rebecca D Huffstutler, et al.
Page
of 58
Search research articles
Search
Showing results (471-480 of 575) with videos related to
Sort By:
Page
of 58
The Journal of Rheumatology
|
January 15, 2023
Safety of Guselkumab With and Without Prior Tumor Necrosis Factor Inhibitor Treatment: Pooled Results Across 4 Studies in Patients With Psoriatic Arthritis
Proton Rahman, Wolf-Henning Boehncke, Philip J Mease, et al.
Rheumatology and Therapy
|
May 5, 2025
Correction: Safety and Efficacy of Bimekizumab in Patients with Psoriatic Arthritis: 2-Year Results from Two Phase 3 Studies
Philip J Mease, Joseph F Merola, Yoshiya Tanaka, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
March 28, 2026
Ixekizumab With Tirzepatide Achieved Greater Disease Control Than Ixekizumab Alone in Adults With Psoriatic Arthritis and Overweight or Obesity: Results From a Randomized Clinical Trial
Joseph F Merola, Philip Mease, Alan Kivitz, et al.
Nature Medicine
|
October 6, 2025
Sonelokimab, an IL-17A/IL-17F-inhibiting nanobody for active psoriatic arthritis: a randomized, placebo-controlled phase 2 trial
Iain B McInnes, Laura C Coates, Philip J Mease, et al.
Seminars in Arthritis and Rheumatism
|
August 16, 2021
OMERACT Filter 2.1 instrument selection for physical function domain in psoriatic arthritis: Provisional endorsement for HAQ-DI and SF-36 PF
Ying-Ying Leung, Ana-Maria Orbai, Pil Hojgaard, et al.
RMD Open
|
August 25, 2025
Efficacy of risankizumab across GRAPPA domains in psoriatic arthritis: a pooled analysis of patients from the phase 3 KEEPsAKE 1 and 2 studies
Laura C Coates, Ricardo Blanco, Frank Behrens, et al.
Rheumatology and Therapy
|
August 31, 2024
Safety and Efficacy of Bimekizumab in Patients with Psoriatic Arthritis: 2-Year Results from Two Phase 3 Studies
Philip J Mease, Joseph F Merola, Yoshiya Tanaka, et al.
Rheumatology and Therapy
|
May 10, 2025
Summary of Research: Safety and Efficacy of Bimekizumab in Patients with Psoriatic Arthritis: 2-Year Results from Two Phase 3 Studies
Philip J Mease, Joseph F Merola, Yoshiya Tanaka, et al.
Seminars in Arthritis and Rheumatism
|
September 14, 2020
Clinical trial discrimination of physical function instruments for psoriatic arthritis: A systematic review
Ying-Ying Leung, Richard Holland, Ashish J Mathew, et al.
JMIR Research Protocols
|
August 15, 2025
Effects of Acute Time-Restricted Eating on Inflammation in Individuals With Psoriasis: Protocol for a Case-Control, Prospective Study
Sinibaldo Romero Arocha, Kim Han, Rebecca D Huffstutler, et al.
Page
of 58